U.S. Pharmaceutical Preparation Market Report 2018 - Analysis and Forecast 2007-2025 - ResearchAndMarkets.com
The "U.S. Pharmaceutical Preparation Market Analysis and Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The report provides on a detailed study of the U.S. pharmaceutical preparation market. It displays the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the industry, including industry life cycle, business locations, productivity, employment and many other crucial aspects. The Company Profiles section contains actual data on the leading players in the industry.
- Pharmaceutical preparations, affecting neoplasms, the endocrine system, and metabolic diseases, for human use
- Pharmaceutical preparations, acting on the central nervous system and the sense organs, for human use
- Pharmaceutical preparations, acting on the cardiovascular system, for human use
- Pharmaceutical preparations, acting on the respiratory system, for human use
- Pharmaceutical preparations, acting on the digestive or the genito-urinary systems, for human use
- Pharmaceutical preparations, acting on skin, for human use
- Pharmaceutical preparations, vitamin, nutrient, and hematinic preparations, for human use
- Pharmaceutical preparations, affecting parasitic and infective diseases, for human use (excluding diagnostics)
- Pharmaceutical preparations for veterinary use (including medicinal premixes and medicated pet care products
Key Topics Covered:
2. Executive Summary
3. Market Overview
4. Most Promising Products
5. Most Promising Supplying Countries
6. Most Promising Overseas Markets
10. Profiles Of Major Producers
- Pfizer Inc.
- Merck & Co.
- Abbott Laboratories
- Abbvie Inc.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Baxter International
- Biogen, Glaxosmithkline
- Celgene Corporation
- Perrigo Company
- Mylan Inc.
- Regeneron Pharmaceuticals
- Novartis Corporation
- Alexion Pharmaceuticals
- Genzyme Corporation
- Sanofi US Services
- Olympus Partners
- Valeant Pharmaceuticals International
- Merck Sharp & Dohme Corp.
- Glaxosmithkline Holdings (Americas)
- Astrazeneca Pharmaceuticals
- Actavis Inc.
- Alcon Laboratories Holding Corporation
- Roche Holdings
For more information about this report visit https://www.researchandmarkets.com/research/2j6cf3/u_s?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181108005861/en/